Marex Group plc Ordinary Shares (MRX) Bundle
Marex Group Beats Third-Quarter Earnings and Revenue Forecasts
Marex Group (NASDAQ:MRX) on November 6, 2025, reported third-quarter financial results that surpassed analyst expectations, driven by strategic acquisitions and strong client activity.
The financial services company posted earnings per share of $1.07, outperforming the estimated $0.92. Revenue for the quarter reached $500.1 million, exceeding the anticipated $481.25 million. This marks the fourth consecutive quarter of positive earnings surprises, with an average surprise of 11.58%.
Preliminary third-quarter results indicate a profit before tax of up to $101 million. The company's return on equity (ROE) is nearing 27%, indicating high efficiency in generating profit from shareholder investments. The company's current ratio stands at about 1.32, reflecting its capacity to meet short-term liabilities.
Valuation metrics place Marex Group with a price-to-earnings (P/E) ratio of approximately 11.41 and a price-to-sales ratio of about 0.83. The company's earnings yield is approximately 8.77%. More information on the company's performance is available on its financial health and investor profile pages.
Marex Group plc Ordinary Shares (MRX) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.